Senior insider sale
EVP, Strategy & Innovation at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$330.3K
7.14K shares
What this filing means
ROBIN SHERRINGTON plans to sell 7.14K shares of XENON PHARMACEUTICALS INC. valued at approximately $330.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/7/2024ACC: 0000950170-24-028232
Officer· EVP, Strategy & Innovation
Since Sep 2019
7.14K
Shares to sell
$330.3K
Approx. market value
7.14K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Options
Net Exercise
3/7/2024
7.14KTotal acquired7.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/7/2024 | Exercise of Options Net Exercise | 7.14K | — |
| Total | 7.14K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.14K
Market value
$330.3K
3/7/2024
Total
Units
7.14K
Value
$330.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/7/2024 | 7.14K | $330.3K | NASDAQ | Planned |
| Total | 7.14K | $330.3K | ||